NCT06683547

Brief Summary

This study investigates how orally ingested exogenous ketone monoester supplements affect circulating hormone concentrations in healthy young adult males after a single session of resistance exercise. Resistance exercise is known to stimulate an acute increase in the circulating concentration of various hormones that are involved in the regulation of muscle mass, including testosterone, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Recently, there has been growing interest in how nutritional supplements impact these natural hormone responses at rest. One such intervention is the oral ingestion of exogenous ketone body supplements. Ketone bodies (i.e., β-hydroxybutyrate (β-HB), acetoacetate (AcAc), and acetone) are naturally occurring compounds that are normally produced by the body during prolonged fasting/starvation, or in response to a "ketogenic" diet (a diet very high in fat and very low in carbohydrates). These ketone body supplements taken in the form of a ketone monoester can quickly raise blood ketone levels without needing to change your diet. Recent research has shown that the ingestion of exogenous ketone supplements or following a 'ketogenic diet' can alter the concentration of certain hormones measured in blood samples at rest. However, the effects of ketone monoester intake on the exercise-induced elevation in circulating hormones is yet to be explored. Therefore, the purpose of this study is to examine how elevated β-HB, induced via the ingestion of the ketone monoester (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate, affects blood concentrations of various anabolic hormones, during post-exercise recovery in healthy young adult males, compared to a placebo drink (flavoured water).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 6, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2025

Completed
Last Updated

September 2, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

November 8, 2024

Last Update Submit

August 28, 2025

Conditions

Keywords

Ketone bodiesExogenous ketone supplementsResistance exerciseTestosteroneAnabolic hormonesKetone monoester

Outcome Measures

Primary Outcomes (2)

  • Area under the curve for testosterone concentration.

    Serum concentration of testosterone (nmol/l) and corresponding area under the curve (AUC), measured at baseline and over 4 hours into the post-exercise recovery period.

    Baseline and over 4 hours into the post-exercise recovery period

  • Time-course data for testosterone concentration.

    Serum concentration of testosterone (nmol/l) measured at baseline and at 13 timepoints (t = -60, -45, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180, 240 min).

    Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.

Secondary Outcomes (24)

  • Area under the curve for growth hormone concentration

    Baseline and over 4 hours into the post-exercise recovery period

  • Time-course data for growth hormone concentration.

    Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.

  • Area under the curve for insulin-like growth factor-1 (IGF-1) concentration

    Baseline and 4 hours into the post-exercise recovery period

  • Time-course data for IGF-1 concentration

    Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.

  • Area under the curve for cortisol concentration.

    Baseline and over 4 hours into the post-exercise recovery period.

  • +19 more secondary outcomes

Study Arms (2)

Ketone Monoester (KET)

ACTIVE COMPARATOR

Ketone monoester supplement: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate dosed based on participants' body weight (0.36g/kg body weight). The nutritional beverage will be consumed twice: 30 minutes prior to the exercise workout (t = -60 min) and immediately following the completion of the exercise protocol (t = 0 min).

Dietary Supplement: Ketone Monoester (KET)Other: Resistance Exercise

Placebo drink

PLACEBO COMPARATOR

Flavoured water. Participants will consume this beverage twice: 30 minutes prior to the exercise workout (t = -60 min) and immediately following the completion of the exercise protocol (t = 0 min).

Dietary Supplement: Flavour matched placebo drink (CON)Other: Resistance Exercise

Interventions

Ketone Monoester (KET)DIETARY_SUPPLEMENT

Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester.

Ketone Monoester (KET)

\- Flavoured water (non-caloric bitter + citrus flavours)

Placebo drink

\- 5 sets of 10 repetitions of leg press and 3 sets of 12 repetitions of leg extension/leg curl 'supersets' (1 set of each back to back with no rest in between sets) at 95% of their 10-RM. Between-set rest intervals for the leg exercises will be 60 seconds.

Ketone Monoester (KET)Placebo drink

Eligibility Criteria

Age18 Years - 40 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsCis males
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adult male participants who are 18-40 years of age (inclusive).
  • BMI \>18.5 and \<30.0 kg/m2
  • Recreationally active (at least of 150 minutes of activity/week).

You may not qualify if:

  • Be willing to entirely avoid alcohol consumption 48 hours prior to the test days.
  • Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
  • Individuals with metabolic disorders including: Type I or Type II diabetes.
  • Individuals with a history of thrombosis / cardiovascular disease, endocrine disorders
  • Individuals with knee injuries (i.e., ACL injuries).
  • Individuals with a positive medical history of unstable thyroid disease (i.e., hypothyroidism, hyperthyroidism, hyperparathyroidism, and hypoparathyroidism) and immune disorders.
  • Individuals who have used tobacco products within the last 6 months.
  • Chronic usage of medications known to modulate hormone levels (i.e. corticosteroids and hormone replacement therapy (HRT)) in the last 6 months.
  • Current use of ketone supplements or adherence to a ketogenic diet.
  • Formal or regular weightlifting activity within the last year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McGill University

Montreal, Quebec, H2W 1S4, Canada

Location

MeSH Terms

Conditions

Ketosis

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Tyler Churchward-Venne, PhD

    Department of Kinesiology and Physical Education, McGill University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants, Investigators and Outcome Accessors will be blinded to the intervention and control drinks. The drinks will be flavor matched and provided in an opaque bottle. An individual not involved with the study data collection, analysis and interpretation will be designated as a study blinder and randomizer.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 12, 2024

Study Start

January 6, 2025

Primary Completion

July 27, 2025

Study Completion

July 27, 2025

Last Updated

September 2, 2025

Record last verified: 2025-01

Locations